Skip to main content
Top
Published in: Supportive Care in Cancer 3/2021

Open Access 01-03-2021 | Cytostatic Therapy | Original Article

Demand for weekend outpatient chemotherapy among patients with cancer in Japan

Authors: Hideki Katayama, Masahiro Tabata, Toshio Kubo, Katsuyuki Kiura, Junji Matsuoka, Yoshinobu Maeda

Published in: Supportive Care in Cancer | Issue 3/2021

Login to get access

Abstract

Background

Advanced cancer therapeutics have improved patient survival, leading to an increase in the number of patients who require long-term outpatient chemotherapy. However, the available schedule options for chemotherapy are generally limited to traditional business hours.

Method

In 2017, we surveyed 721 patients with cancer in Okayama, Japan, regarding their preferences for evening and weekend (Friday evening, Saturday, and Sunday) chemotherapy appointments.

Results

A preference for evening and weekend appointment options was indicated by 37% of the respondents. Patients who requested weekend chemotherapy were younger, female, with no spouse or partner, living alone, employed, and currently receiving treatment. Among these factors, age and employment status were significantly associated with a preference for weekend chemotherapy, according to multivariate analysis.

Conclusion

Our findings reveal a demand for evening and weekend outpatient chemotherapy, especially among young, employed patients.
Literature
3.
go back to reference Takano N, Ariyasu R, Koyama J, Sonoda T, Saiki M, Kawashima Y, Oguri T, Hisakane K, Uchibori K, Nishikawa S, Kitazono S, Yanagitani N, Ohyanagi F, Horiike A, Gemma A, Nishio M (2019) Improvement in the survival of patients with stage IV non-small-cell lung cancer: experience in a single institutional 1995–2017. Lung Cancer 131:69–77. https://doi.org/10.1016/j.lungcan.2019.03.008CrossRefPubMed Takano N, Ariyasu R, Koyama J, Sonoda T, Saiki M, Kawashima Y, Oguri T, Hisakane K, Uchibori K, Nishikawa S, Kitazono S, Yanagitani N, Ohyanagi F, Horiike A, Gemma A, Nishio M (2019) Improvement in the survival of patients with stage IV non-small-cell lung cancer: experience in a single institutional 1995–2017. Lung Cancer 131:69–77. https://​doi.​org/​10.​1016/​j.​lungcan.​2019.​03.​008CrossRefPubMed
4.
go back to reference Uramoto H, Kagami S, Iwashige A, Tsukada J (2007) Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in Japan. Anticancer Res 27:1127–1132PubMed Uramoto H, Kagami S, Iwashige A, Tsukada J (2007) Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in Japan. Anticancer Res 27:1127–1132PubMed
8.
go back to reference Yamada K, Yoshida T, Zaizen Y, Okayama Y, Naito Y, Yamashita F, Takeoka H, Mizoguchi Y, Yamada K, Azuma K (2011) Clinical practice in management of hydration for lung cancer patients receiving cisplatin-based chemotherapy in Japan: a questionnaire survey. Jpn J Clin Oncol 41:1308–1311. https://doi.org/10.1093/jjco/hyr145CrossRefPubMed Yamada K, Yoshida T, Zaizen Y, Okayama Y, Naito Y, Yamashita F, Takeoka H, Mizoguchi Y, Yamada K, Azuma K (2011) Clinical practice in management of hydration for lung cancer patients receiving cisplatin-based chemotherapy in Japan: a questionnaire survey. Jpn J Clin Oncol 41:1308–1311. https://​doi.​org/​10.​1093/​jjco/​hyr145CrossRefPubMed
10.
go back to reference Ricci RP, Vicentini A, D’Onofrio A, Sagone A, Vincenti A, Padeletti L, Morichelli L, Fusco A, Vecchione F, Lo Presti F, Denaro A, Pollastrelli A, Santini M (2013) Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population. J Interv Card Electrophysiol 38:101–106. https://doi.org/10.1007/s10840-013-9823-5CrossRefPubMed Ricci RP, Vicentini A, D’Onofrio A, Sagone A, Vincenti A, Padeletti L, Morichelli L, Fusco A, Vecchione F, Lo Presti F, Denaro A, Pollastrelli A, Santini M (2013) Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population. J Interv Card Electrophysiol 38:101–106. https://​doi.​org/​10.​1007/​s10840-013-9823-5CrossRefPubMed
Metadata
Title
Demand for weekend outpatient chemotherapy among patients with cancer in Japan
Authors
Hideki Katayama
Masahiro Tabata
Toshio Kubo
Katsuyuki Kiura
Junji Matsuoka
Yoshinobu Maeda
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05575-x

Other articles of this Issue 3/2021

Supportive Care in Cancer 3/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine